{"cdcTestId":"2020-0015","testcaseName":"2nd dose of Covid-19 Vaccine different product (Moderna) at an interval of 28 days","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2021-01-30T00:00:00","patient":{"dob":"2002-06-24T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2021-01-02T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2021-01-30T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"207","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2021-06-30T00:00:00","recommendedDate":"2021-06-30T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2021-01-02T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2021-01-30T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"207","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-09-27T09:32:13.487","generalDescription":"This test case describes when a patient is administered a different Covid-19 vaccine (Moderna) at 28 days after the first dose,  that the dose is valid.  A booster dose should be forecast.","changedInVersion":"4.27","reasonForChange":"v4.27  Updated test case to a fixed date test case to retain previous booster recommendations before the updated Covid-19 Interim Clinical Guidance (09/02/2022). \nv4.18 Updated the Forecast Earliest and Recommended dates based on ACIP/Clinical Consideration that individuals should receive a booster dose of Covid-19 vaccine at an interval of 5 months after completion of a primary series (01/06/2022).\nv4.16 Updated the Forecast Recommended Date based on Clinical Considerations Information (11/29/21), that states all persons aged 18 years and older should received a booster dose of Covid-19 vaccine.\nv4.15 Updated per ACIP Recommendation on 11/19/2021, where individuals 18 years and older may receive a booster dose.\nv4.13 - Updated test case to include the forecasting of a booster dose, at an interval of 6 months from most recent dose, for individuals 65 years and older who have completed a primary series.\nv4.8: Changed age of patient from 16 to 20. This test case was intended to test mixed product use, but was testing both mixed product and minimum ages. The outcome is the same (2 valid doses with a complete series)."}